CN102026656A - 促进伤口愈合的方法 - Google Patents

促进伤口愈合的方法 Download PDF

Info

Publication number
CN102026656A
CN102026656A CN2009801177576A CN200980117757A CN102026656A CN 102026656 A CN102026656 A CN 102026656A CN 2009801177576 A CN2009801177576 A CN 2009801177576A CN 200980117757 A CN200980117757 A CN 200980117757A CN 102026656 A CN102026656 A CN 102026656A
Authority
CN
China
Prior art keywords
relaxin
wound
skin
individual
healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801177576A
Other languages
English (en)
Chinese (zh)
Inventor
D·R·斯图尔特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corthera Inc
Original Assignee
Corthera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41319048&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102026656(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corthera Inc filed Critical Corthera Inc
Priority to CN201610133215.XA priority Critical patent/CN105688192A/zh
Publication of CN102026656A publication Critical patent/CN102026656A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN2009801177576A 2008-05-16 2009-05-13 促进伤口愈合的方法 Pending CN102026656A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610133215.XA CN105688192A (zh) 2008-05-16 2009-05-13 促进伤口愈合的方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12794708P 2008-05-16 2008-05-16
US61/127,947 2008-05-16
PCT/US2009/043854 WO2009140433A1 (en) 2008-05-16 2009-05-13 Method of promoting wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201610133215.XA Division CN105688192A (zh) 2008-05-16 2009-05-13 促进伤口愈合的方法

Publications (1)

Publication Number Publication Date
CN102026656A true CN102026656A (zh) 2011-04-20

Family

ID=41319048

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2009801177576A Pending CN102026656A (zh) 2008-05-16 2009-05-13 促进伤口愈合的方法
CN201610133215.XA Pending CN105688192A (zh) 2008-05-16 2009-05-13 促进伤口愈合的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201610133215.XA Pending CN105688192A (zh) 2008-05-16 2009-05-13 促进伤口愈合的方法

Country Status (10)

Country Link
US (2) US20110092439A1 (enExample)
EP (1) EP2278993A4 (enExample)
JP (3) JP2011520902A (enExample)
CN (2) CN102026656A (enExample)
AU (1) AU2009246333B2 (enExample)
BR (1) BRPI0912560A2 (enExample)
CA (1) CA2724308C (enExample)
MX (1) MX2010012454A (enExample)
RU (1) RU2506092C2 (enExample)
WO (1) WO2009140433A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106999549A (zh) * 2014-12-09 2017-08-01 加利福尼亚大学董事会 促进组织愈合和修复的方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014530242A (ja) * 2011-10-13 2014-11-17 ガデック，トーマス 皮膚疾病の処置用のケメリンｃ１５ペプチドの局所製剤
US20150150947A1 (en) * 2012-07-31 2015-06-04 Elaine Unemori Treating inflammation using serelaxin
AU2014326298B2 (en) * 2013-09-26 2019-07-04 Galderma Holding SA Prostaglandin F2alpha and analogues thereof for treating atrophic cutaneous scarring
WO2017100540A2 (en) 2015-12-09 2017-06-15 The California Institute For Biomedical Research Relaxin immunoglobulin fusion proteins and methods of use
JP6955736B2 (ja) * 2016-09-14 2021-10-27 ヤンマーパワーテクノロジー株式会社 水生生物の飼育装置
BR112019016139A2 (pt) 2017-02-08 2020-04-07 Bristol-Myers Squibb Company polipeptídio de relaxina modificada compreendendo um melhorador farmacocinético e usos do mesmo

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3003917A (en) * 1959-01-14 1961-10-10 Nat Drug Co Wound healing composition
CH661662A5 (en) * 1984-04-16 1987-08-14 Georg L Prof Dr Floersheim Product for the treatment of the skin and of the connective tissue
US4863733A (en) * 1985-08-28 1989-09-05 Startz Jack P Method of preparing treatment compositions for use in plastic or cosmetic surgery
ATE88352T1 (de) * 1988-02-26 1993-05-15 Genentech Inc Humanes relaxinpraeparat.
US4969880A (en) * 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US5100396A (en) * 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
WO1996033733A1 (en) * 1995-04-25 1996-10-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel remedy for skin deficiencies
EP0845992B1 (en) * 1995-08-15 2002-11-20 Connetics Corporation Use of relaxin for promoting angiogenesis
US6176854B1 (en) * 1997-10-08 2001-01-23 Robert Roy Cone Percutaneous laser treatment
US7550143B2 (en) * 2005-04-06 2009-06-23 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
US7534866B2 (en) * 2005-10-19 2009-05-19 Ibc Pharmaceuticals, Inc. Methods and compositions for generating bioactive assemblies of increased complexity and uses
US6723702B2 (en) * 2000-02-09 2004-04-20 Ras Medical, Inc. Use of relaxin treat diseases related to vasoconstriction
CA2456753A1 (en) * 2001-08-17 2003-02-27 The Board Of Trustees Of The Leland Stanford Junior University Mammalian relaxin receptors
ATE340572T1 (de) * 2001-12-07 2006-10-15 Applied Research Systems Benzazole derivate zur behandlung von scleroderma
US7591994B2 (en) * 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
US8877901B2 (en) * 2002-12-13 2014-11-04 Immunomedics, Inc. Camptothecin-binding moiety conjugates
AU2003216375A1 (en) * 2002-02-28 2003-09-16 Immunex Corporation Rank-ligand-induced sodium/proton antiporter polypeptides
EP1572242B1 (en) * 2002-12-13 2014-04-16 Immunomedics, Inc. Immunoconjugates with an intracellularly-cleavable linkage
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
US7738952B2 (en) * 2003-06-09 2010-06-15 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
US20050153885A1 (en) * 2003-10-08 2005-07-14 Yun Anthony J. Treatment of conditions through modulation of the autonomic nervous system
WO2006107617A2 (en) * 2005-04-06 2006-10-12 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
US8569277B2 (en) * 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
US20090088374A1 (en) * 2005-01-07 2009-04-02 Judithann Lee Novel use
CN101534865A (zh) * 2005-10-19 2009-09-16 Ibc药品公司 生物活性装配体的制备方法及其用途
CN102871857A (zh) * 2005-12-15 2013-01-16 卢塞迪奥·格莱西 新型氮氧化物抗氧化剂的合成和在化妆用和皮肤病用组合物中的使用方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106999549A (zh) * 2014-12-09 2017-08-01 加利福尼亚大学董事会 促进组织愈合和修复的方法

Also Published As

Publication number Publication date
CN105688192A (zh) 2016-06-22
MX2010012454A (es) 2011-03-29
RU2010151472A (ru) 2012-06-27
EP2278993A4 (en) 2012-09-12
JP2011520902A (ja) 2011-07-21
JP2014129392A (ja) 2014-07-10
US20110092439A1 (en) 2011-04-21
CA2724308A1 (en) 2009-11-19
BRPI0912560A2 (pt) 2019-09-24
EP2278993A1 (en) 2011-02-02
JP2016179990A (ja) 2016-10-13
WO2009140433A1 (en) 2009-11-19
US20100041603A1 (en) 2010-02-18
AU2009246333A1 (en) 2009-11-19
RU2506092C2 (ru) 2014-02-10
CA2724308C (en) 2016-08-16
AU2009246333B2 (en) 2013-05-09

Similar Documents

Publication Publication Date Title
JP2016179990A (ja) 創傷の治癒を促進する方法
KR20180114911A (ko) 침습 및 비침습 시술적 피부 관리를 위한 조성물 및 방법
CN107847558A (zh) 用于促进伤口愈合的组合物
CN1251530A (zh) 具有催产素活性的物质在制备用于创伤愈合的药剂方面的应用
JP4102437B2 (ja) アクチビンおよびインヒビン刺激因子を含有する医薬組成物
US8455443B2 (en) Methods of use of skin wound healing compositions
US20250277010A1 (en) Agent for treatment of dermatological disorders
EP2635293B1 (en) Skin wound healing compositions and methods of use thereof
JP5300281B2 (ja) 創傷治療剤および創傷治療用組成物
US20200000890A1 (en) Use of apc analogue for wound healing
KR20100126396A (ko) 피부의 노화 및 반흔 치료제
US20220062381A1 (en) Methods for promoting wound healing and hair growth
AU2013204203A1 (en) Method of promoting wound healing
KR20240117782A (ko) 켈로이드 치료를 위한 피부 패치와 주사 치료제 조성물
Patil et al. Colloidal carriers for noninvasive delivery of insulin
EP3490572A1 (en) Skin care formulation
CN107979996A (zh) 新的皮肤医疗和美容护理产品
Berlanga Heberprot-P: experimental background and pharmacological bases
HK40047629A (zh) 皮肤病治疗剂
HK1230520A1 (en) Use of apc analogue for wound healing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20110420